ArticleMaterials (Basel, Switzerland)2025
Development and Characterization of Zn-ZnO Nanocomposites for Enhanced Biodegradable Material Properties.
Article in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Experimental investigation on enhancing the mechanical properties of biodegradable Zn-3Mg alloys reinforced with snail-shell particulates via powder metallurgy.Journal of materials science. Materials in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Zinc has attracted significant attention as a versatile material with potential applications in various fields, particularly in biomedical engineering. Despite its desirable characteristics, such as biodegradability and biocompatibility, the inherently low mechanical strength of zinc has been a major limitation for its broader use in clinical applications. To address this issue and enhance its mechanical performance without compromising its biocompatibility, a novel composite material was developed by mixing zinc oxide (ZnO) with zinc (Zn). ZnO is widely recognized for its high chemical stability, non-toxicity, and antimicrobial properties, making it an excellent additive for biomedical materials. In this study, Zn-ZnO nanocomposites were fabricated by uniformly dispersing ZnO nanoparticles into molten zinc using an ultrasonic processor. The uniform distribution of ZnO nanoparticles within the zinc matrix was confirmed, and the resulting nanocomposites demonstrated remarkable improvements in mechanical properties. Specifically, the hardness and tensile strength of the Zn-ZnO nanocomposites were increased by approximately 90% and 160%, respectively, compared to pure zinc. To evaluate the biodegradation behavior of the materials, both pure zinc and Zn-ZnO nanocomposite samples were immersed in phosphate-buffered saline (PBS) at 37 °C, simulating physiological conditions. The degradation rate was assessed by measuring the weight loss of the material over time. The biodegradation rate of the Zn-ZnO nanocomposites was found to be nearly identical to that of pure zinc under identical conditions, indicating that the addition of ZnO did not adversely affect the degradability of the material. These findings suggest that Zn-ZnO nanocomposites offer a promising solution for biomedical applications by combining improved mechanical properties with maintained biodegradability and biocompatibility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.